Filing Details
- Accession Number:
- 0000882104-20-000196
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-12-04 21:17:15
- Reporting Period:
- 2020-12-03
- Accepted Time:
- 2020-12-04 21:17:15
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 882104 | Pdl Biopharma Inc. | PDLI | Biological Products, (No Disgnostic Substances) (2836) | 943023969 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1202335 | W David Gryska | 932 Southwood Blvd. Incline Village NV 89451 | Yes | No | No | No |
Transaction Summary
| Sold: | 75,000 shares | Avg. Price: $2.52 | Total Value: $189,000.00 |
| Number of Shares After Transactions: | 30,337 shares | ||
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2020-12-03 | 75,000 | $2.52 | 30,337 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Billionaire Hedge Funds
